newsfilter
← Latest News
GlobeNewswire·

Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies

ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved insulin sensitivity, enhanced adipose function, and improved liver